NMD Pharma66% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Forendo Pharma65% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- At least one other investor: Merck Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
AMRA55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
OxThera55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Sunstone Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Acarix55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Seventure Partners, Sunstone Capital, SEED Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Orphazyme55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Sunstone Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
ITBMed54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Oncoinvent54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Merozyne Therapeutics46% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
|
Antag46% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
|
BioPhero45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
Biosyntia45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
Acesion Pharma45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|
Vivino44% | - Similar business models: B2B
- At least one vc investor: SEED Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Flatfrog44% | - Similar business models: B2B
- At least one vc investor: Sunstone Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
BoneSupport44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
Natural Cycles44% | - Similar verticals: Health services
- At least one vc investor: Sunstone Capital
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Optomed44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|
TILT Biotherapeutics44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
Chundsell Medicals44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|